Neonatal jaundice refers to yellowing of the skin and eyes in newborn babies due to high levels of bilirubin. Jaundice meters are handheld, non-invasive diagnostic devices used to measure bilirubin levels in infants. These devices provide quick, accurate and painless bilirubin level readings to enable timely treatment and management of jaundice. The global neonatal jaundice meter market is estimated to be valued at US$ 107.24 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The global neonatal jaundice meter market is witnessing significant growth owing to the rising prevalence of neonatal jaundice. As per the World Health Organization (WHO), an estimated 60% of newborns worldwide develop jaundice, with countries in South Asia and sub-Saharan Africa having the highest rates. Early detection and treatment of jaundice is critical to prevent complications such as chronic bilirubin encephalopathy, auditory dysfunction and cerebral palsy. This is increasing demand for jaundice meters which offer a rapid, non-invasive way to measure bilirubin levels. Additionally, technological advancements leading to development of user-friendly, portable jaundice meters with LED lighting systems and touchscreen displays for simplified operation are further augmenting market growth over the forecast period. Moreover, growing awareness about premature birth and related health conditions in developing regions is also expected to present lucrative opportunities.

SWOT Analysis

Strength: Global Jaundice Meter Market Size have advanced accuracy and efficiency in detecting jaundice levels compared to traditional methods. They provide quick and reliable measurements which help doctors make prompt diagnosis and treatment decisions. Home-use jaundice meters also enable parents to frequently monitor infant's jaundice levels from the comfort of home.

Weakness: High costs associated with jaundice meters limit their adoption in resource-poor regions. Accuracy of results may vary depending on proper use and placement of the device on infant's skin.

Opportunity: Rising neonatal jaundice cases worldwide present a large patient pool. Growing awareness about advanteges of early jaundice detection and home monitoring creates demand. Developing accurate and affordable jaundice meters specifically suited for home use expands addressable market.

Threats: Stiff competition among existing players limits price and margin growth potential. Stringent regulatory approvals for new product launches delays their commercialization. Alternate traditional detection methods like physical examination also continue in many regions.

Key Takeaways

The global jaundice meter market is expected to witness high growth over the forecast period of 2024 to 2031.

North America currently dominates the market owing to increasing neonatal jaundice prevalence, growing public health awareness, and advanced healthcare infrastructure. However, Asia Pacific is expected emerge as the fastest growing region due to large neonatal population, rising healthcare expenditure, and growing adoption of point-of-care diagnostic devices in countries like China and India.

Key players operating in the jaundice meter market are Aegis Medicals, Refine Medical Technology, Delta Medical International, Micro Lab, and Dräger. These established companies have strong global presence and offer a wide range of jaundice detection products targeting hospitals, clinics as well as homecare applications. Leading players are investing in new product development with advanced technologies to consolidate their market shares.

Get More Insights On This Topic: https://www.trendingwebwire.com/jaundice-meter-market-analysis-growth-forecast-outlook-2023-2030/